Navigating Globe Life Stock – Key Insights for Investors

By Naomi Wentworth • Wednesday, April 24 15:10 • Permanent Link

Globe Life logged a 6.8% change during today's afternoon session, and is now trading at a price of $80.94 per share. The S&P 500 index moved -0.0%. GL's trading volume is 4,519,436 compared to the stock's average volume of 2,387,474.

Globe Life trades -31.84% away from its average analyst target price of $118.75 per share. The 8 analysts following the stock have set target prices ranging from $80.0 to $160.0, and on average have given Globe Life a rating of hold.

If you are considering an investment in GL, you'll want to know the following:

Globe Life's current price is -21.2% below its Graham number of $102.71, which implies the stock has a margin of safety
Globe Life has moved -28.1% over the last year, and the S&P 500 logged a change of 25.0%
Based on its trailing earnings per share of 10.46, Globe Life has a trailing 12 month Price to Earnings (P/E) ratio of 7.7 while the S&P 500 average is 15.97
GL has a forward P/E ratio of 6.4 based on its forward 12 month price to earnings (EPS) of $12.69 per share
The company has a price to earnings growth (PEG) ratio of 0.44 — a number near or below 1 signifying that Globe Life is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 1.69 compared to its sector average of 1.58
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States.
Based in McKinney, the company has 3,636 full time employees and a market cap of $7.61 Billion. Globe Life currently returns an annual dividend yield of 0.9%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.